Latvia Pharmaceuticals and Healthcare Report Q1 2014:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Fun with Brazilian Portuguese Learn the tips and tricks to speak colloquial Portuguese in a natural and confident manner. Enroll today for just $69! From our sponsors

Latvia Pharmaceuticals and Healthcare Report Q1 2014 Nov 20th 2013, 00:00, by vyankatesh BMI View: After several years of budget cuts, which have had an impact on the healthcare sector, Latvia’s pharmaceutical market is re-emerging with steady growth forecast. Spending on pharmaceuticals will be driven by the strength of the private sector since the market has a high proportion of out-of-pocket expenditure. Meanwhile, the country’s manufacturing sector should benefit from its anticipated membership of the eurozone, which remains on track. Headline Expenditure Projections ? Pharmaceuticals: LVL221mn (US$307mn) in 2012 to LVL230mn (US$432mn) in 2013; +4.0% in local currency terms and +6.1% in US dollar terms. Forecast broadly unchanged from previous quarter. ? Healthcare: … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=131623. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/latvia-pharmaceuticals-and-healthcare-report-q1-2014-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions